92 related articles for article (PubMed ID: 1318463)
1. Characterization of EBV-positive lymphoblastoid cell lines obtained from HIV seropositive patients with or without lymphomas.
Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Dodi F; Foa R; Rowe M; Ferrarini M
Leukemia; 1992; 6 Suppl 3():12S-14S. PubMed ID: 1318463
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
4. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
[TBL] [Abstract][Full Text] [Related]
6. Production of inflammatory cytokines by Epstein-Barr virus (EBV)-infected lymphoblastoid cell lines spontaneously originated from the peripheral blood of patients with human immunodeficiency virus (HIV) infection.
Roncella S; Baldi L; Cutrona G; Viale M; Rizzo F; Gasco M; Ferrarini M; Pistoia V
Clin Immunol Immunopathol; 1995 Nov; 77(2):162-71. PubMed ID: 7586723
[TBL] [Abstract][Full Text] [Related]
7. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
9. Human B-lymphoid cell lines.
Nilsson K
Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
[TBL] [Abstract][Full Text] [Related]
10. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
[TBL] [Abstract][Full Text] [Related]
12. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
13. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
14. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.
Birx DL; Redfield RR; Tosato G
N Engl J Med; 1986 Apr; 314(14):874-9. PubMed ID: 3005862
[TBL] [Abstract][Full Text] [Related]
15. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
Masucci MG; Klein E
Semin Cancer Biol; 1991 Feb; 2(1):63-71. PubMed ID: 1655115
[TBL] [Abstract][Full Text] [Related]
16. Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
Jilg W; Voltz R; Markert-Hahn C; Mairhofer H; Münz I; Wolf H
Cancer Res; 1991 Jan; 51(1):27-32. PubMed ID: 1899042
[TBL] [Abstract][Full Text] [Related]
17. fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection.
Cheah MS; Ley TJ; Tronick SR; Robbins KC
Nature; 1986 Jan 16-22; 319(6050):238-40. PubMed ID: 3003578
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.
Gregory CD; Kirchgens C; Edwards CF; Young LS; Rowe M; Forster A; Rabbitts TH; Rickinson AB
Eur J Immunol; 1987 Aug; 17(8):1199-207. PubMed ID: 3040424
[TBL] [Abstract][Full Text] [Related]
19. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
Becker Y; Tabor E; Asher Y
Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
